1)Wang G﹟, Jiang G﹟, Jing W, Zong Z, Yu X, Chen S, Li W, Huang H*. Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey. J Infect. 2021;82(3):371-377.
3)Sun Q﹟, Wang S﹟, Liao X, Jiang G, Huang H, Li H*, Wang G*. Fidaxomicin has high in vitro activity against Mycobacterium tuberculosis. J Med Microbiol. 2021;70(3). doi: 10.1099/jmm.0.001324.
3)Wang G﹟, Wang S﹟, Yang X﹟, Sun Q, Jiang G, Huang M, Huo F, Ma Y, Chen X*, Huang H*. Accuracy of Xpert MTB/RIF Ultra for the Diagnosis of Pleural TB in a Multicenter Cohort Study. Chest. 2020;157(2):268-75.
4)Sun Q﹟, Wang S﹟, Dong W﹟, Jiang G, Huo F, Ma Y, Huang H*, Wang G*. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. J Infect. 2019;79(2):153-8.
5)Wang G﹟, Wang S﹟, Jiang G﹟, Yang X﹟, Huang M, Huo F, Ma Y, Dai G, Li W, Chen X*, Huang H*. Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study. J Infect. 2019;78(4):311-6.